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Abstract
Background: Measurement of treatment satisfaction in diabetes is important as it has been shown to be associated 
with positive outcomes, reduced disease cost and better health.
Aim: The aim of this study was to assess the relationship between treatment satisfaction of diabetes patients and 
socioeconomic, clinical, medication adherence and health‑related factors in Qatar.
Design: This is a cross‑sectional study.
Setting: The survey was carried out in primary health care centers and hospitals from April 2010 to May 2011.
Subjects: Of a total of 3000 diabetic patients, 2582 patients gave their consent to take part in the study, with a response 
rate of 86.1%.
Materials and Methods: The Diabetes Treatment Satisfaction Questionnaire was used to measure the patient satisfaction. 
The modified Morisky Medication Adherence was used to measure medication taking behavior. A multivariate stepwise 
linear regression model was performed to identify factors independently associated with patients’ satisfaction instrument.
Results: Of  the studied patients, majority of  the diabetes patients were Qataris  (61.2%), married  (86.1%), above 
secondary education (46.9%) and unemployed (28.6%). Diabetes patients who had professional  jobs (3.97 ± 0.65; 
P = 0.009) and  those who were staying alone had a significantly higher  treatment satisfaction score  (4.01 ± 0.64; 
P = 0.001) compared with the other patients. Patients who were taking tablets were significantly more satisfied with 
treatment (4.08 ± 0.60; P < 0.001). Diabetes patients of primary health care centers (3.96 vs. 3.80; P < 0.001) were 
more satisfied with treatment than patients visiting hospitals. Multivariate regression analysis revealed that age of the 
patient (P < 0.001), expatriates (P = 0.023), patients visiting hospitals (P < 0.001), treatment with insulin (P < 0.001) 
and any diabetes complications (P < 0.001) were significantly less satisfied with the treatment.
Conclusion: The study findings revealed that patient satisfaction was positively associated with sociodemographic 
variables like high income, employment, married individuals and those with higher levels of education. We found a 
lower treatment satisfaction in patients with diabetes‑related complications and insulin treatment.
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Diabetes mellitus (DM) is one of the major non‑communicable 
diseases with a dramatically increasing prevalence in both 
the developed and the developing world.[1] In recent times, 
the Middle East region has seen some of the largest growth 
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in DM in the world; five out of the top 10 countries with the 
highest diabetes prevalence are in the Middle East region, 
and trends predict that the region will see over 90% growth 
in the disease by 2030.[1‑3] These perturbing trends are a 
result of the dramatic changes in dietary and lifestyle habits 
in this rapidly economically developing region.[4] In line with 
global trends, the most sociodemographically vulnerable 
populations in the region have been found to be the main 
victims of the diabetes epidemic, namely those of lower 
socioeconomic status (SES), females and the elderly.[5‑8]
DM also has a more detrimental impact on females’ 
psychological well‑being.[7‑9] A 5 years cohort study among 
Qatari patients with DM reported that females found it 
more difficult to cope with DM and reported worse “Quality 
of Life” in comparison with males.[7] Another Swedish 
study conducted among Type 2 diabetes mellitus (T2DM) 
primary health care patients documented similar gender 
results, and reported glycosylated hemoglobin (HbA1c) 
as the most important factor associated with coping 
strategies.[10] A more recent study in Israel[5] showed that 
lower treatment satisfaction is related to difficulties in 
adherence to taking medications and attending follow‑up 
clinic visits, treatment with insulin or oral medications, any 
diabetes complication, being female and having had less 
than 6 years of education. Several studies have evaluated 
the relationship of diabetic treatment satisfaction with 
different treatment modalities, its quality, patients’ quality 
of life, and clinical outcome.[5,11‑13]
Patients are inclined to make the best of their current 
treatment and only become aware of its drawbacks when 
they can compare it with something better.[9] A frequently 
observed feature in trials of new treatments for diabetes 
is therefore a relatively high level of patient satisfaction 
with pre‑trial treatment.[7,10‑15] Patient satisfaction surveys 
produce little variation and most respondents express 
positive satisfaction.[6] Researchers evaluating diabetes 
treatment interventions have commonly used the Diabetes 
Treatment Satisfaction Questionnaire (DTSQ) in its 
original “status” form.[7,10‑15] Treatment satisfaction is an 
important fact of quality of care, especially in treating 
chronic diseases such as DM.[5] Identifying factors that 
independently influence treatment satisfaction may help 
in improving clinical outcomes.
The aim of this study was to determine the association 
between treatment satisfaction of diabetes patients and 
socioeconomic, medication adherence and clinical outcome 
in a community‑based sample of diabetes patients in Qatar.
Materials and Methods
This is a cross‑sectional study that was conducted among 
the diabetic patients registered in diabetic clinics of primary 
health care (PHC) centers and outpatient clinics of the 
hospitals. The diabetes care is organized in most of the 
PHC centers. During the study period from April 2010 
to May 2011, the study included the diabetic patients 
registered in these diabetic clinics. From the patients 
diagnosed with diabetes in hospitals and PHCs, we have 
approached 3000 diabetic patients, of whom 2582 agreed 
and gave their consent to take part in this study thus giving 
a response rate of 86.1%. Institutional Review Board ethical 
approval for this study was obtained from the Hamad 
Medical Corporation prior to commencing data collection.
Questionnaire
We have developed a structured questionnaire consisting 
of questions relating to sociodemographic data, treatment 
modality, symptoms of diabetes, diabetic complications and 
place of diabetic treatment. The second section included 
items about laboratory investigations such as blood glucose, 
HbA1C, high‑density lipoprotein (HDL) and low‑density 
lipoprotein (LDL) cholesterol levels and triglyceride. The 
third section is the DTSQ[13] consisting of eight questions 
concerning the treatment for diabetes and experience over 
the past few weeks. The fourth section is the Modified 
Morisky Medication Adherence questionnaire concerning 
the questions related to issues of medication taking behavior. 
The fifth section included items concerning mode of 
treatment, symptoms of diabetes and complications after 
the onset of diabetes.
Diabetes treatment satisfaction questionnaire
The DTSQ was developed from the widely used and 
recommended DTSQs[9,13‑15] available in a wide range of 
languages,[16,17] the development of which is reported in 
detail elsewhere.[13,14] Both forms of the DTSQ are suitable 
for use by people with type 1 or type 2 diabetes. The DTSQ 
contains eight items scored on six‑point scales. Six items 
(Qs. 1 and 4‑8) measure treatment satisfaction (dealing 
with: Satisfaction with current treatment; convenience 
of the treatment; flexibility; satisfaction with own 
understanding of their diabetes; how likely to recommend 
their present treatment; and how satisfied to continue with 
their present treatment). These are summed to produce 
a total Treatment Satisfaction score. Questions 2 and 3, 
concerning the level of blood sugar, are treated separately 
from the satisfaction items and from each other.[13‑15] On 
these two items, low scores represent good perceived 
blood glucose control. The important differences lie in the 
wording of the response options and instructions, which, 
in the DTSQ, direct the respondent to compare their 
experience of the current treatment with their experience 
of treatment before the study began. DTSQs scores range 
from, for example, 6 = very satisfied to 0 = very dissatisfied.
Modified morisky medication adherence scale
The modified Morisky Medication Adherence Scale 
(MMAS‑8) is an eight‑item self‑report measure of 
adherence[18]. The single composite measure was scored 
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according to the developers’ instructions so that higher 
scores indicate higher adherence. Individuals have identified 
several issues regarding their medication taking behavior. 
Each question was based on their personal experience with 
the medication taking behavior. The first seven questions 
are scored with “yes = 1” and “No = 0.” Question 8 
concerning the difficulty to remember taking medications 
is scored “Never/Rarely = 0,” “Once in a while = 1,” 
“sometimes = 2,” “usually = 3” and “all the time = 4.”
Anthropometric examination and measurements
Anthropometric examination and measurements were 
performed by a trained nurse. Height was measured in 
centimeters using a height scale (SECA, Germany) while 
the subject was standing bare feet and with normal straight 
posture. Weight was measured in kilograms using a weight 
scale (SECA). Body Mass Index (BMI) was calculated as the 
ratio of weight (kg) to the square of height (m). A person 
was considered obese if the BMI value was ≥30 kg/m2, 
overweight if BMI >25 kg/m2 and <30 kg/m2.
Laboratory measurements and diabetes diagnosis
Oral Glucose Tolerance Test (OGTT): A 75 gm OGTT was 
performed after 10 h overnight fast and the plasma glucose 
concentration was measured before and 2 h after the glucose 
drink. HbA1C was analyzed using a high‑performance liquid 
chromatography (HPLC) method. The diagnosis of T2DM 
was performed according to the ADA criteria, i.e., (1) fasting 
venous plasma glucose concentration ≥7.0 mmol/L, (2) 2‑h 
venous plasma glucose concentration ≥11.1 mmol/L or 
(3) HbA1c ≥6.5%. Subjects reporting a history of DM and 
receiving antihyperglycemic therapy were also considered 
as having DM. Information about lipid profile (total 
cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) 
was collected from the medical records.
Diabetes symptoms and complications
The PHC department and outpatient clinics of the 
hospitals have their own medical record sections and 
they are responsible for the files of their patients. Family 
physicians and research nurses reviewed the medical files 
of diabetic patients in both the settings and recorded all 
the required clinical variables of this study. Research nurses 
have collected diabetic complications like retinopathy, 
neuropathy, nephropathy and diabetic foot ulcer from the 
medical records of the patients.
The questionnaire and criteria for relationship between 
patient satisfaction with diabetes care and treatment 
were defined and developed by the primary investigator. 
A translated Arabic version of the designed questionnaire 
was revised by a bilingual consultant. The qualified nurses, 
who were fluent in Arabic language, performed face‑to‑face 
interview with the patients. They have completed the 
designed questionnaires interviewing the participants and 
some of the clinical information was recorded from the 
medical records of the patients. The designed questionnaire 
was tested among 100 patients as a pilot study for the validity 
of the questionnaire. The investigators have made the 
necessary corrections and modifications after considering 
the minor differences and discrepancies that have been 
found during the pilot study.
Student’s t‑test was used to ascertain the significance of 
differences between the mean values of two continuous 
variables and confirmed by the non‑parametric 
Mann–Whitney test. One‑way ANOVA with post hoc 
pairwise comparison through least significant difference 
LSD was used to ascertain the significance of the difference 
between the mean values of more than two continuous 
variables. Chi‑square and Fisher exact tests were performed 
to test for differences in proportions of categorical variables 
between two or more groups. A multivariate linear regression 
model with stepwise elimination was constructed to identify 
the determinants of diabetes treatment satisfaction while 
adjusting for the potential confounders. The level P < 0.05 
was considered as the cut‑off value for significance.
Results
Table 1 shows the sociodemographic and clinical 
characteristics of the studied diabetes patients according 
to gender. Majority of the diabetic patients (30.8%) 
were in the age group of 50‑59 years with a significant 
difference (P = 0.001). Most of the patients were 
Qataris (61.2%), married (86.1%), with secondary 
education (27.9%) and unemployed (28.6%) and 60.3% 
had high‑level income (>$3,000). Diabetes complications 
of nephropathy (10.9% vs. 8.5%; P = 0.034) and 
neuropathy (14.6% vs. 10.7%; P = 0.003) were significantly 
higher in diabetic men compared with women, whereas 
retinopathy was significantly higher in women (20.1% vs. 
16.8%; P = 0.032) than in men.
Table 2 reveals the relationship between treatment 
satisfaction and sociodemographic characteristics of the 
studied diabetes patients. The overall mean score of 
treatment satisfaction was 3.91 ± 0.64. Diabetes patients 
who had professional jobs (3.97 ± 0.65; P = 0.009) and 
those who were staying alone had a significantly higher 
satisfaction score (4.01 ± 0.64; P = 0.001) compared with 
their counterparts. Satisfaction scores of diabetic patients 
who had university education (3.93 ± 0.67) and average 
income of $3000 or above (3.92 ± 0.62) were slightly 
higher than their counterparts, but the difference was not 
statistically significant.
Table 3 shows the relationship between treatment 
satisfaction and diabetes treatment modalities and diabetic 
complications in diabetic patients. In treatment modality, 
patients who were taking tablets were significantly more 
satisfied with the treatment of diabetes (4.08 ± 0.60; 
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P < 0.001). Diabetic patients visiting PHCs (3.96 ± 0.60) 
were significantly more satisfied with treatment than 
patients visiting hospitals (3.80 ± 0.71) (P < 0.001).
Table 4 presents the relationship between treatment 
satisfaction of patients with their laboratory investigations. 
Patients who had optimum level in their lab investigations were 
significantly more satisfied with the treatment; fasting blood 
glucose (3.94 ± 0.65 vs. 3.87 ± 0.63; P = 0.007), HbA1C 
(4.1 ± 0.49 vs. 3.85 ± 0.66; P = 0.023), total cholesterol 
level (4.02 ± 0.53 vs. 3.76 ± 0.59; P = 0.001), triglycerides 
(3.90 ± 0.67 vs. 3.84 ± 0.62; P = 0.035), HDL (3.92 ± 0.64 
vs. 3.86 ± 0.57; P = 0.045) and LDL (3.96 ± 0.65 vs. 
3.90 ± 0.59; P = 0.021).
Table 5 shows the medication taking behaviors of the 
studied diabetic patients according to gender. Majority 
of the diabetic men (89.8%) and women (89.4%) did not 
forget to take their medicines, while a good proportion 
of diabetic men (17.3%) and women (18.7%) stopped 
taking medication without the knowledge of their doctors. 
Also, nearly one‑fourth of the diabetic men (21.6%) and 
Table 1: Sociodemographic and clinical characteristics 











Duration of diabetes in 
years (mean±SD)
7.69±5.1 7.59±5.4 7.78±4.6 0.366
Age (in years)
<30 212 (8.2) 92 (7.1) 120 (9.3) 0.001
30‑39 304 (11.8) 168 (13.0) 136 (10.6)
40‑49 627 (24.3) 292 (22.5) 335 (26.1)
50‑59 794 (30.8) 438 (33.8) 356 (27.7)
60 and above 645 (25.0) 307 (23.7) 338 (26.3)
Nationality
Qatari 1580 (61.2) 624 (48.1) 956 (74.4) <0.001
Non‑Qatari 1002 (38.8) 673 (51.9) 329 (25.6)
Marital status
Single 173 (6.7) 83 (6.4) 90 (7.0) <0.001
Married 2223 (86.1) 1161 (89.5) 1062 (82.6)
Divorced/widow 186 (7.2) 53 (4.1) 133 (10.3)
BMI
Normal<25 717 (27.8) 417 (32.2) 300 (23.3) <0.001
Overweight (25‑29.9) 1189 (46.0) 582 (44.9) 607 (47.2)
Obese (30 and above) 676 (26.2) 298 (23.0) 378 (29.4)
Consanguinity
Yes 981 (38.0) 524 (40.4) 457 (35.6) 0.011
No 1601 (62.0) 773 (59.6) 828 (64.4)
Level of education
Illiterate 420 (16.3) 188 (14.5) 232 (18.1) 0.002
Primary 435 (16.8) 225 (17.3) 210 (16.3)
Intermediate 517 (20.0) 267 (20.6) 250 (19.5)
Secondary 720 (27.9) 339 (26.1) 381 (29.6)
University 490 (19.0) 278 (21.4) 212 (16.5)
Occupation
Housewife/unemployed 738 (28.6) 83 (6.4) 655 (51.0) <0.001
Sedentary/professional 650 (25.2) 400 (30.8) 250 (19.5)
Clerk 586 (22.7) 416 (32.1) 170 (13.2)
Businessmen 245 (9.5) 162 (12.5) 83 (6.5)
Army/police 203 (7.9) 121 (9.3) 82 (6.4)
Manual 160 (6.2) 115 (8.9) 45 (3.5)
Household income ($ US) per month
<$3000 1026 (39.7) 493 (38.0) 533 (41.5) 0.072
≥$3000 1556 (60.3) 804 (62.0) 752 (58.5)
Current level of 
HbA1c (mean±SD)
9.15±14.1 8.39±2.1 8.56±2.0 0.075
Diabetes complications
Retinopathy 476 (18.4) 218 (16.8) 258 (20.1) 0.032
Nephropathy 251 (9.7) 142 (10.9) 109 (8.5) 0.034
Neuropathy 326 (12.6) 189 (14.6) 137 (10.7) 0.003
Antipathy 164 (6.4) 78 (6.0) 86 (6.7) 0.480
Diabetic foot ulcer 299 (11.6) 154 (11.9) 145 (11.3) 0.640
DTSQ=Diabetes treatment satisfaction questionnaire (scale ranging from 
0=lowest to 6=highest)
Table 2: Relationship between treatment satisfaction 
and sociodemographic characteristics of diabetic 
patients (n=2582)
Variables Mean DTSQ 
score±SD
P value




























DTSQ=Diabetes treatment satisfaction questionnaire (scale ranging from 
0=lowest to 6=highest). aSignificantly different from groups 2, 4 and 5. 
bSignificantly different from group 2. cSignificantly. different from groups 
1 and 3. dSignificantly different from groups 2 and 6. eSignificantly 
different from groups 1 and 4
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women (23%) stopped taking medicines when they found 
that their health status improved.
Table 6 shows the multiple linear regression analysis 
examining the relation between all statistically significant 
parameters and DTSQ scores. The data revealed that the 
satisfaction score for expatriate patients (Adj. β ‑0.47, 
P = 0.023) was lower than that for Qataris. Also, satisfaction 
score for patients receiving care from hospital was 1.41‑times 
lower than those receiving care from PHCs (Adj. β ‑1.41, P 
< 0.001). No diabetes complication (Adj. β 1.86, P < 0.001) 
and treatment with tablets (Adj. β 1.62, P < 0.001) were 
significantly associated with higher treatment satisfaction.
Discussion
Patient satisfaction is considered as a main component of 
the quality of medical care. Hence, determining the patient 
satisfaction level is an important way of improving health 
care. The authors of the current study took the initiative to 
conduct this large study surveying 2582 diabetes patients in 
Qatar to evaluate their treatment satisfaction. This is the 
first study conducted in Qatar to investigate the relationship 
between treatment satisfaction and sociodemographic 
characteristics, treatment modalities, diabetic complications 
and medication taking behaviors in diabetic patients. The 
DTSQ, which was used to evaluate the satisfaction score, 
rated a mean score of 3.8 to 4 in all parameters of diabetic 
patients, which shows that diabetes patients rated a higher 
degree of satisfaction. The overall mean score of treatment 
satisfaction was 3.91 ± 0.64.
As for treatment satisfaction in the study sample, a 
number of sociodemographic variables were associated 
with satisfaction score. Diabetic men (mean score of 3.92) 
were more satisfied with treatment than women (mean 
score of 3.90), which is consistent with the findings in 
Sweden[19] and Italy.[20] Diabetic patients who were staying 
alone (4.01 ± 0.64; P = 0.001) and had professional 
jobs (3.97 ± 0.65; P = 0.009) were significantly more 
satisfied with treatment than their counterparts. Another 
study by Biderman et al.[5] also observed similar results, 
wherein married patients were less satisfied with treatment 
than unmarried patients. In the study sample of diabetes 
patients, highly educated patients (3.93 ± 0.67) and 
professionals (3.97 ± 0.65; P = 0.009) had a higher 
satisfaction score compared with other patients, which is in 
line with another study[19] that reported that less‑educated 
patients were less satisfied with diabetes treatment. Age 
of the diabetic patients was a contradicting factor in the 
current study, wherein it was shown that younger patients 
were more satisfied with treatment. In other studies,[11] 
Table 3: Relationship between treatment satisfaction 
and diabetes treatment modalities and diabetes 
complications in diabetic patients (n=2582)
Mean DTSQ score±SD P value
Treatment modality
None (n=523) 3.86±0.69 <0.001






Yes (n=476) 3.87±0.69 0.179
No (n=2106) 3.92±0.63
Neuropathy
Yes (n=326) 3.98±0.61 0.040
No (n=2256) 3.90±0.64
Nephropathy
Yes (n=251) 3.89±0.62 0.695
No (n=2331) 3.91±0.64
Diabetic foot ulcer
Yes (n=299) 4.05±0.49 <0.001
No (n=2283) 3.89±0.65
Antipathy
Yes (n=164) 3.86±0.68 0.314
No (n=2418) 3.91±0.64
Place of diabetic treatment
Primary health care (n=1768) 3.96±0.60 <0.001
Hospital (n=814) 3.80±0.71
Diabetic education
Yes (n=1946) 3.92±0.65 0.312
No (n=636) 3.89±0.61
DTSQ=Diabetes treatment satisfaction questionnaire (scale ranging from 
0=lowest to 6=highest) *Significantly different from all others
Table 4: Relationship between treatment satisfaction 
and laboratory investigations among diabetic 
patients (n=2582)
Mean DTSQ score±SD P value
Fasting blood glucose
Optimum (<7.0 mmol/L) 3.94±0.65 0.007
High (≥7.0 mmol/L) 3.87±0.63
HbA1C levels
Optimum (<6.5) 4.10±0.49 0.023
High (≥6.5) 3.85±0.66
Total cholesterol level
Optimum (<5.17) 4.02±0.53 0.001
Borderline and high (≥5.17) 3.76±0.59
Triglycerides level
Optimum (<1.7) 3.90±0.67 0.035
Borderline and high (≥1.7) 3.84±0.62
HDL cholesterol
Low (<1.0) 3.92±0.64 0.045
Desirable (≥1.0) 3.86±0.57
LDL cholesterol
Optimum (<3.36) 3.96±0.65 0.021
Borderline and high (≥3.36) 3.90±0.59
DTSQ=Diabetes treatment satisfaction questionnaire (0=lowest, 6=highest)
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it was observed that younger patients were less satisfied 
with treatment. In the study sample of diabetic patients, 
satisfaction was positively associated with higher income, 
employment and higher educational level, as observed in 
other studies.[19‑21] These study findings show that patients’ 
satisfaction with diabetes treatment was influenced by their 
sociodemographic characteristics.
Regarding the treatment modality, patients who were taking 
tablets (4.08 ± 0.60; P < 0.001) had higher satisfaction 
scores, with a significant difference with other treatments. 
Similar to other studies,[19] insulin users of this study 
sample had a lower satisfaction score than those who were 
receiving other medications. This shows that taking a pill 
is more comfortable for diabetes patients rather injecting 
insulin. It could be due to the reason that patients might 
think insulin treatment means that their health status has 
deteriorated, and another possible explanation is that more 
complications are prevalent in type 1 diabetes patients. Of 
all the diabetes complications, retinopathy and antipathy 
were associated with the lowest treatment satisfaction. The 
satisfaction scores were lower in patients with complications, 
which is similar to the results reported in a study of Al‑Aujan 
et al.[22] Koopmanschap et al.[23] reported in their study 
that diabetes complications had a significant impact on 
treatment satisfaction. A significant difference was observed 
in the satisfaction rates of diabetes patients visiting PHCs 
Table 6: Multivariable linear regression for the 
association between treatment satisfaction and 
sociodemographic, clinical parameters, diabetic 
complications and treatment factors (n=2582)
Parameter Adj. β (95% CI) P value
Age (in years) −0.03 (−0.04, −0.01) <0.001
Nationality (non‑Qatari vs. Qatari) −0.47 (−0.87, −0.06) 0.023
Treatment center (hospital vs. PHC) −1.41 (−1.84, −0.97) <0.001
Current treatment 
(tablets vs. any other treatment)
1.62 (1.16, 2.09) <0.001
Diabetes complication 
(none versus any)
1.86 (1.38, 3.73) <0.001
Coefficient of correlation (r=0.20), coefficient of 
determination (r2=0.04). Dependent variable: Treatment satisfaction 
score (range 0‑48)
Table 5: Medication taking behaviors* of the studied diabetic patients according to gender (n=2582)
Male, n=1297 (%) Female, n=1285 (%) P value
Do you sometimes forget to take medicine?
Yes 132 (10.2) 136 (10.6) 0.735
No 1165 (89.8) 1149 (89.4)
People sometimes miss taking their medications for reasons other than forgetting. Thinking 
over the past two weeks, were there any days when you did not take your medicine?
Yes 45 (3.5) 60 (4.7) 0.123
No 1252 (96.5) 1225 (95.3)
Have you ever cut back or stopped taking your medication without telling your doctor, 
because you felt worse when you took it?
Yes 224 (17.3) 240 (18.7) 0.352
No 1073 (82.7) 1045 (81.3)
When you travel or leave home, do you sometimes forget to bring along your medication?
Yes 110 (8.5) 97 (7.5) 0.383
No 1187 (91.5) 1188 (92.5)
Did you take your medicine daily?
Yes 1220 (94.1) 1186 (92.3) 0.075
No 77 (5.9) 99 (7.7)
When you feel like your health concern is under control, do you sometimes stop taking 
your medicine?
Yes 280 (21.6) 296 (23.0) 0.377
No 1017 (78.4) 989 (77.0)
Taking medication everyday is a real inconvenience for some people. Do you ever feel 
hassled about sticking to your blood pressure treatment plan?
Yes 105 (8.1) 116 (9.0) 0.398
No 1192 (91.9) 1169 (91.0)
How often do you have difficulty remembering to take all your medications?
Never/rarely 836 (64.5) 820 (63.8) <0.001
Once in a while 122 (9.4) 181 (14.1)
Sometimes 148 (11.4) 108 (8.4)
Usually 125 (9.6) 83 (6.5)
All the time 66 (5.1) 93 (7.2)
*Modified morisky scale. P values based on the Chi square‑test of significance
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and those visiting hospitals. Patients taking treatment from 
health centers (3.96 ± 0.60 vs. 3.8 ± 0.71; P < 0.001) had 
a significantly higher satisfaction score when compared with 
patients taking treatment from hospitals.
The data on medication taking behaviors of the diabetes 
patients revealed that adherence to taking medications 
as prescribed was good, and only 10.4% of the studied 
diabetic patients forgot to take their medicine. But, nearly 
one‑fourth of the diabetic patients (22.3%) stopped taking 
their medication once they found that their health status 
had improved, and 18% of them stopped their medicines 
without the knowledge of their doctors. Difficulty in taking 
medications is related to lower satisfaction. The treatment 
satisfaction was significantly higher in patients with optimum 
biochemical values (mean values from 3.92 to 4.10). 
Diabetic patients with an HbA1C level of <6.5 scored the 
highest satisfaction mean scores of 4.10 (P = 0.023), which 
was significantly different from that of their counterparts. 
Multivariate analysis confirmed the study findings that the 
lower treatment satisfaction is significantly related to taking 
insulin, any diabetes complication, being an expatriate and 
age of the patient. Similar observations with multivariate 
analysis were reported in other studies.[5,20,21]
In the study sample of diabetic patients, a number of 
sociodemographic parameters were positively related 
to treatment satisfaction, which affected their quality 
of life and patient satisfaction. It is important to target 
those patients who are treated with insulin, have diabetes 
complications and have difficulties in adherence with 
medications. The study identified the sociodemographically 
vulnerable population among the diabetic patients in 
Qatar who needed more attention. This study supports 
the fact that patient satisfaction surveys can be an integral 
component of assessing care.
The limitations of the study need to be noted. The study 
sample includes Qataris and non‑Qataris, which is a 
heterogeneous group, and their satisfaction responses can be 
different according to their culture, behavior and practice. 
Hence, responses might vary from nationality to nationality. 
Also, answers of the participants to the questionnaires 
might not be accurate, which will affect the accuracy of 
their answers.
Conclusion
The study findings revealed that a positive association 
was found between diabetes patients’ satisfaction with 
care and treatment. Patient satisfaction was positively 
associated with sociodemographic variables like high 
income, employment, married individuals and those with 
higher levels of education. We found lower treatment 
satisfaction in patients with diabetes‑related complications. 
Being unemployed and living alone had a particularly strong 
correlation with treatment satisfaction. The study identified 
the more disadvantaged diabetes patients who needed more 
attention in improving their health status.
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